Tolerance to pentylentetrazol-induced convulsions and protection of cerebrovascular integrity by chronic nicotine

International Journal of Neuroscience

Volumn 114, Issue 6, 2004, Pages 735-748

  Üzüm, Gülay ^a   Bahçekapili, Nesrin ^a   Diler, A Sarper ^a   Ziylan, Y Ziya ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Blood brain barrier; Mecamylamine; Nicotine; Pentylentetrazol; Seizures

Indexed keywords

EVANS BLUE; MECAMYLAMINE; NICOTINE; PENTETRAZOLE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN BLOOD VESSEL; BRAIN REGION; BRAIN WATER; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CONVULSION; INJECTION; LATENT PERIOD; MALE; NEUROPROTECTION; NONHUMAN; PROTEIN CONTENT; RAT; RELATIVE DENSITY; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; TONIC CLONIC SEIZURE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG TOLERANCE; EVANS BLUE; MALE; MECAMYLAMINE; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES; SPECIFIC GRAVITY; TIME FACTORS;

EID: 2542507270     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450490440975     Document Type: Article

References (35)

1. Ates, N., Üzüm, G., Diler, A. S., & Ziylan, Y. Z. (1992). The cerebrovascular permeability and epilepsy: The role of blood pressure. Neuroscience Research Communications, 10, 163-169.
2. Barrios, V., Rodriguez-Sanchez, M. N., Colas, B., & Arilla, E. (1990). Effects of acute nicotine and mecamylamine administration on somatostatin concentration and binding in the rat brain. European Journal of Pharmacology, 25, 263-270.
3. Belluarda, N., Mudo, G., Blum, M., & Fuxe, K. (2000). Central nicotinic receptors, neurotrophic factors and neuroprotection. Behavioral Brain Research, 113, 21-24.
4. Bertrand, D., Picard, F., LeHellard, S., Weiland, S., Favre, I., Phillips, H., Bertrand, S., Berkovic, S. F., Malafose, A., & Mulley, J. (2002). How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia, 43, 112-122.
5. Borlongan, C. V., Shytle, R. D., Ross, S. D., Shimizu, T., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1995). (-)Nicotine protects against systemic kainic acid-induced excitotoxic effects. Experimental Neurology, 136, 261-265.
6. Buisson, B., & Bertrand, D. (2001). Chronic exposure to nicotine upregulates the human (alpha)4 (beta)2nicotinic acetylcholine receptor function. Journal of Neuroscience, 15, 1819-1829.
7. Collins, A. C., Evans, L. L., Miner, L. L., & Marks, M. J. (1986). Mecamylamine blockade of nicotine responses: Evidence for two brain nicotinic receptors. Pharmacology Biochemistry Behavioral, 24, 1767-1773.
8. Dagci, I., Tan, M., Koylu, E. O., Tan U., & Pogun, S. (2002). The effect of octreotide on kainite-induced wet dog shakes and seizure activity in male and female rats. International Journal of Neuroscience, 112, 829-839.
9. Damaj, M. I., Glassco, M., Dukat, M., & Martin, B. R. (1999). Pharmacological characterization of nicotine-induced seizures in mice. Journal of Pharmacology & Experimental Therapeutics, 291, 1284-1291.
10. Dani, J. A. (2000). Properties underlying the influence of nicotinic receptors on neuronal excitability and epilepsy. Epilepsia, 41, 1063-1065.
11. Fusco, M. D., Becchetti, A., Patrignani, A., Annesi, G., Gambardella, A., Quattrone, A., Ballabio, A., Wanke, E., & Casari, G. (2000). The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genetics, 26, 275-276.
12. Hendryk, S., Jedrzejowska Szypulka, H., Josko, J., Jarzab, B., & Döhler, K. D. (2002). Influence of the corticotrophin releasing hormone (CRH) on the brain-blood barrier permeability in cerebral ischemia in rats. Journal of Physiology & Pharmacology, 53(1), 85-94.
13. Hosli, E., & Hosli, E. (1994). Colocalization of binding sites for somatostatin, muscarine and nicotine on cultured neurons of rat neocortex, cerebellum, brain stem and spinal cord: Combined autoradiographic and immunohistochemical studies. Neuroscience Letter, 173, 71-74.
14. Hulien-Gublin, B. A., Lumpkin, M. D., & Kellar, K. J. (1990). Effects of chronic administration of nicotine on prolactin release in the rat: Inactivation of prolactin response by repeated injections of nicotine. Journal Pharmacology & Experimental Therapeutics, 252, 21-25.
15. Jones, S., Sudweeks, S., & Yakel, J. L. (1999). Nicotinic receptors in the brain: Correlating physiology with function. Trends in Neurosciences, 2, 555-561.
16. Ke, L., Eisenhour, C. M., Bencherif, M., & Lukas, R. J. (1998). Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. Journal Pharmacology & Experimental Therapeutics, 286, 825-840.
17. Kim, H.-C., Jhoo, W.-K., HoKo, K., Kim, W.-K., Bing, G., Kwon, M.-S., Shin, E.-J., Suh, J.-H., Lee, Y.-G., & Lee, D.-W. (2000). Prolonged exposure to cigarette smoke blocks the neurotoxicity induced by kainic acid in rats. Life Sciences, 66, 317-326.
18. Klatzo, I. (1983). Disturbances of the blood-brain barrier in cerebrovascular disorders. Acta Neuropathologica Supplementum, 8, 81-88.
19. McDonough, J. H., & Shih, T. M. (1995). A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacology Biochemistry Behavior, 51, 249-253.
20. Nelson, S., & Manz, M. (1971). Use of specific gravity in the measurement of cerebral edema. Journal Applied Physiology, 30, 268-271.
21. Newman, M. B., Manresa, J. J., Sanberg, P. R., & Shytle, D. (2001). Nicotine induced seizures blocked by mecamylamine and its stereoisomers. Life Sciences, 69, 2583-2591.
22. Papke, R. L., Sanberg, P. R., & Shytle, R. D. (2001). Analysis of mecamylamine stereoisomers on human nicotinic receptor subtypes. Journal of Pharmacology and Experimental Therapeutics, 297, 646-656.
23. Pogun, S., Demirgoren, S., Taskiran, D., Kanit, L., Yilmaz, O., Koylu, E., Balkan, B., & London, E. D. (2000). Nicotine modulates nitric oxide in rat brain. European Neuropsychopharmacology, 10, 463-472.
24. Prendergast, M. A, Harris, B. R., Mayer, S., Holley, R. C., Pauly, J. R., & Littleton, J. M. (2001). Nicotine exposure reduces N-methyl-D-aspartate toxicity in the hippocampus: Relation to distribution of the alpha 7 nicotinic acetylcholine receptor subunit. Medical Science Monitoring, 7(6), 1153-1160.
25. Rössner, N., & Tempel, K. (1966). Quantitative Bestimmung der Permeabilitat dersagenonnten blut-hirnschranke für Evans-blue (t1824). Medical Pharmacology Experimental, 14, 169-182.
26. Shytle, R. D., Borlongan, C. V., & Sanberg, P. R. (1995). Nicotine blocks kainic acid-induced wet dog shakes in rats. Neuropsychopharmacology, 13, 261-264.
27. Summers, K. L., & Glacabini, E. (1995). Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex. Neurochemical Research, 20, 753-759.
28. Tan, M., Kalyoncu, N. I., & Tan, U. (2002). Sex difference in susceptibility to picrotoxine-induced seizures in rats following octreotide. International Journal of Neuroscience, 112, 903-911.
29. Üzüm, G., Diler, A. S., & Ziylan, Y. Z. (1999). Chronic nicotine pretreatment protects the blood-brain barrier against nicotine-induced seizures in the rat. Pharmacological Research, 40, 263-269.
30. Üzüm, G., Curgunlu, S., Hacialioglu, M., Ercan, S., Diler, A. S., & Ziylan, Y. Z. (1993). Protective effect of chronic administration of nicotine on neuronal and vascular functions in the brain. European Journal Neuroscience Supplementum, 6, 93.
31. Vezzani, A., & Hoyer, D. (1999). Brain somatostatin: A candidate inhibitory role in seizures and epileptogenesis. European Journal of Neuroscience, 11, 3767-3776.
32. Young, J. M., Shytle, R. D., Sanberg, P. R., & George, T. P. (2001). Mecamylamine: New therapeutic uses and toxicity/risk profile. Clinical Theraupetics, 23, 532-565.
33. Zevin, S., Jacob, P., & Benowitz, N. L. (2000). Nicotine-mecamylamine interactions. Clinical Pharmacology Theraupetics, 68, 58-66.
34. Ziylan, Y. Z., Lefauconnier, J. M., Bernard, G., & Bourre, J. M. (1993). Hormonal influence on permeability of the blood-brain barrier: Effect of an analog of adrenocorticotropic hormone, beta 1-24 corticotropin. Neuroscience Letter, 51, 59-63.
35. Ziylan, Y. Z., & Ates, N. (1989). Age-related changes in regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by pentylentetrazole. Neuroscience Letter, 96, 179-184.